Natasha Krishnadas1,2, Vincent Doré2,3, Fiona Lamb2, Colin Groot4, Paul McCrory5, Rodney Guzman2, Rachel Mulligan2, Kun Huang2, Meaghan O'Donnell6,7, Jennie Ponsford8, Malcolm Hopwood7, Victor L Villemagne2, Christopher C Rowe2,5. 1. Florey Department of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia. 2. Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, VIC, Australia. 3. The Australian e-Health Research Centre, CSIRO Health & Biosecurity, Parkville, VIC, Australia. 4. Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. 5. The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia. 6. Phoenix Australia, Parkville, VIC, Australia. 7. The Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia. 8. Monash-Epworth Rehabilitation Centre, Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC, Australia.
Abstract
Introduction: It remains unclear if tau imaging may assist diagnosis of chronic traumatic encephalopathy (CTE). Flortaucipir PET has shown superior frontal with medial temporal tau binding consistent with the provisional neuropathological criteria for mid-stage CTE in group-level analyses of retired symptomatic NFL players and in one individual with pathologically confirmed CTE. 18F-MK6240 is a new PET ligand that has high affinity for tau. We present the case of a 63-year-old cognitively impaired, former Australian rules football player with distinct superior frontal and medial temporal 18F-MK6240 binding and show it to be significantly different to the pattern seen in prodromal Alzheimer's disease (AD). Findings: The participant was recruited for a study of amyloid-β and tau several decades after traumatic brain injury. He had multiple concussions during his football career but no cognitive complaints at retirement. A thalamic stroke in his mid 50s left stable mild cognitive deficits but family members reported further short-term memory, behavioral, and personality decline preceding the study. Imaging showed extensive small vessel disease on MRI, a moderate burden of amyloid-β plaques, and 18F-MK6240 binding in bilateral superior frontal and medial temporal cortices. Voxel-wise analysis demonstrated that the frontally predominant pattern of the participant was significantly different to the posterior temporo-parietal predominant pattern of prodromal AD. Conclusion: Although lacking neuropathological examination to distinguish CTE from a variant of AD, the clear demonstration of a CTE-like tau pattern in a single at-risk individual suggests further research on the potential of 18F-MK6240 PET for identifying CTE is warranted.
Introduction: It remains unclear if tau imaging may assist diagnosis of chronic traumatic encephalopathy (CTE). Flortaucipir PET has shown superior frontal with medial temporal tau binding consistent with the provisional neuropathological criteria for mid-stage CTE in group-level analyses of retired symptomatic NFL players and in one individual with pathologically confirmed CTE. 18F-MK6240 is a new PET ligand that has high affinity for tau. We present the case of a 63-year-old cognitively impaired, former Australian rules football player with distinct superior frontal and medial temporal 18F-MK6240 binding and show it to be significantly different to the pattern seen in prodromal Alzheimer's disease (AD). Findings: The participant was recruited for a study of amyloid-β and tau several decades after traumatic brain injury. He had multiple concussions during his football career but no cognitive complaints at retirement. A thalamic stroke in his mid 50s left stable mild cognitive deficits but family members reported further short-term memory, behavioral, and personality decline preceding the study. Imaging showed extensive small vessel disease on MRI, a moderate burden of amyloid-β plaques, and 18F-MK6240 binding in bilateral superior frontal and medial temporal cortices. Voxel-wise analysis demonstrated that the frontally predominant pattern of the participant was significantly different to the posterior temporo-parietal predominant pattern of prodromal AD. Conclusion: Although lacking neuropathological examination to distinguish CTE from a variant of AD, the clear demonstration of a CTE-like tau pattern in a single at-risk individual suggests further research on the potential of 18F-MK6240 PET for identifying CTE is warranted.
Authors: Robert A Stern; Charles H Adler; Kewei Chen; Michael Navitsky; Ji Luo; David W Dodick; Michael L Alosco; Yorghos Tripodis; Dhruman D Goradia; Brett Martin; Diego Mastroeni; Nathan G Fritts; Johnny Jarnagin; Michael D Devous; Mark A Mintun; Michael J Pontecorvo; Martha E Shenton; Eric M Reiman Journal: N Engl J Med Date: 2019-04-10 Impact factor: 91.245
Authors: Ann C McKee; Robert A Stern; Christopher J Nowinski; Thor D Stein; Victor E Alvarez; Daniel H Daneshvar; Hyo-Soon Lee; Sydney M Wojtowicz; Garth Hall; Christine M Baugh; David O Riley; Caroline A Kubilus; Kerry A Cormier; Matthew A Jacobs; Brett R Martin; Carmela R Abraham; Tsuneya Ikezu; Robert Ross Reichard; Benjamin L Wolozin; Andrew E Budson; Lee E Goldstein; Neil W Kowall; Robert C Cantu Journal: Brain Date: 2012-12-02 Impact factor: 13.501
Authors: Christian LoBue; Jeff Schaffert; C Munro Cullum; Matthew E Peters; Nyaz Didehbani; John Hart; Charles L White Journal: J Neurol Neurosurg Psychiatry Date: 2020-04-24 Impact factor: 10.154
Authors: Philip H Montenigro; Christine M Baugh; Daniel H Daneshvar; Jesse Mez; Andrew E Budson; Rhoda Au; Douglas I Katz; Robert C Cantu; Robert A Stern Journal: Alzheimers Res Ther Date: 2014-09-24 Impact factor: 6.982
Authors: Cinthya Aguero; Maeva Dhaynaut; Marc D Normandin; Ana C Amaral; Nicolas J Guehl; Ramesh Neelamegam; Marta Marquie; Keith A Johnson; Georges El Fakhri; Matthew P Frosch; Teresa Gomez-Isla Journal: Acta Neuropathol Commun Date: 2019-03-11 Impact factor: 7.801
Authors: Ann C McKee; Nigel J Cairns; Dennis W Dickson; Rebecca D Folkerth; C Dirk Keene; Irene Litvan; Daniel P Perl; Thor D Stein; Jean-Paul Vonsattel; William Stewart; Yorghos Tripodis; John F Crary; Kevin F Bieniek; Kristen Dams-O'Connor; Victor E Alvarez; Wayne A Gordon Journal: Acta Neuropathol Date: 2015-12-14 Impact factor: 17.088
Authors: Michael L Alosco; Yi Su; Thor D Stein; Eric M Reiman; Ann C McKee; Robert A Stern; Hillary Protas; Jonathan D Cherry; Charles H Adler; Laura J Balcer; Charles Bernick; Surya Vamsi Pulukuri; Bobak Abdolmohammadi; Michael J Coleman; Joseph N Palmisano; Yorghos Tripodis; Jesse Mez; Gil D Rabinovici; Kenneth L Marek; Thomas G Beach; Keith A Johnson; Bertrand Russell Huber; Inga Koerte; Alexander P Lin; Sylvain Bouix; Jeffrey L Cummings; Martha E Shenton Journal: Eur J Nucl Med Mol Imaging Date: 2022-09-24 Impact factor: 10.057